Found 15626 matching trials
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer
PHASE4The aim of this study was to evaluate the efficacy, safety and tolerability...
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
PHASE3Palmoplantar psoriasis is a variant of psoriasis affecting palms and soles....
Location
The Guenther Dermatology Research Center
Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff
N/ACOVID-19 is a pathology linked to the SARS-CoV-2 virus, a new virus of the ...
Location
Hôpital d'Instuction des Armées Percy
Delayed Tolerance Through Mixed Chimerism
PHASE1This study will examine the safety and effectiveness of a bone marrow trans...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
N/AThis observational study will evaluate the efficacy and safety of bevacizum...
Location
Clinique Esquirol Saint Hilaire
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
PHASE2The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
PHASE2In this phase II trial, the investigators overarching goal is to demonstrat...
Location
University of Washington
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
PHASE2This study is conducted in 3 stages. Stage 1 is an open-label, dose-escalat...
Location
Multiple Locations
Natalizumab Subcutaneous Immunogenicity and Safety Study
PHASE2The primary objective of this study is to evaluate the immunogenicity of na...
A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas
PHASE1This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Location
Multiple Locations